首页> 外国专利> Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene and their use, combined with a differentiation inducer to cause apoptosis of leukemic blast cells

Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene and their use, combined with a differentiation inducer to cause apoptosis of leukemic blast cells

机译:与人c-fes原癌基因初级转录物互补的反义寡核苷酸及其应用,与分化诱导剂结合,引起白血病母细胞凋亡

摘要

The following description sets forth antisense (AS) oligonucleotides (ODNs) complementary to the primary transcript of the human c-fes protooncogene and their use to inactivate said transcript. All-trans retinoic acid (ATRA) is reported to be used as a differentiation inducer on cells pretreated with said AS-ODNs to induce apoptosis of leukemic blast cells.
机译:以下描述阐述了与人c-fes原癌基因的初级转录物互补的反义(AS)寡核苷酸(ODN)及其在使所述转录物失活中的用途。据报道,全反式维甲酸(ATRA)被用作在用所述AS-ODN预处理的细胞上的分化诱导剂,以诱导白血病母细胞的凋亡。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号